Scientists at The Wistar Institute have developed an HIV vaccine candidate that achieves something never before observed in the field: inducing neutralizing antibodies against HIV after a single ...

In the long battle to create an effective HIV vaccine, scientists have made a major leap forward. A new study shows that a series of vaccines can coax the immune system to produce powerful antibodies ...

Many vaccines work by introducing a protein to the body that resembles part of a virus. Ideally, the immune system will produce long-lasting antibodies recognizing that specific virus, thereby ...

Broadly neutralizing antibodies, or bnAbs, are a long‑standing goal of HIV vaccine research because they can disable many strains of the virus at once.

Worldwide, an estimated 40 million people live with HIV. Two-thirds of this group on the African continent. In 2023, more than 600,000 people died from HIV-related causes and 1.32 million were ...

Solving HIV vaccination—a puzzle that scientists have been tackling for decades without success—could be like cracking the code to a safe. The key, they now think, may be delivering a series of ...

A SCIENTIST AT UNL WAS AWARDED MILLIONS FOR HIS WORK TO DEVELOP A CURE FOR HUMAN, HUMAN IMMUNODEFICIENCY VIRUS, OR HIV. HE’S HOPING THIS WILL END THE DECADES LONG SEARCH FOR ANSWERS. AND KETV ...

An electron density map illustrating how the new antibody (purple) neutralizes HIV by binding across two sections of the spike protein (gray). LA JOLLA, CA—In the long battle to create an effective ...

Scripps Research scientists found that HIV vaccination can lead to the production of anti-immune complex antibodies (blue) that recognize immune complexes composed of antibodies (green) rather than ...